Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  varenicline
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit
Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Genetically Informed Smoking Cessation Interventions in Helping People Quit Smoking
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201305128, NCI-2015-00792, NCT02351167
Varenicline for Smoking Cessation in African American Smokers
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 18 and over
Trial IDs: STUDY00000721, NCI-2015-01529, NCT02360631
Varenicline for Adolescent Smoking Cessation
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Age: 14 to 21
Trial IDs: Pro00014398, NCI-2016-02034, NCT01509547
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients with Newly Diagnosed Lung Cancer Who Smoke Cigarettes
Status: Not yet active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A211401, NCI-2016-00438, NCT02856581
Strategies to Promote Smoking Cessation in Patients with Newly Diagnosed or Recurrent Lung or Head and Neck Cancer
Status: Active
Phase: No phase specified
Type: Behavioral study
Age: 18 and over
Trial IDs: KCTN-1301, NCI-2014-00939, NCI-2014-00879, NCT02048917
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008
Varenicline or Varenicline-Based Adaptive Pharmacotherapy with High or Low Intensity Behavioral Programs in Helping Smokers Quit Smoking
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: Pro00072077, NCI-2017-00062, NCT02501265
Start Over